Literature DB >> 19218854

Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.

Marieke A D van Zoelen1, Huan Yang, Sandrine Florquin, Joost C M Meijers, Shizuo Akira, Bernd Arnold, Peter P Nawroth, Angelika Bierhaus, Kevin J Tracey, Tom van der Poll.   

Abstract

High-mobility group box 1 (HMGB-1) has been reported as a "late" proinflammatory mediator in sepsis. In vitro data have shown that HMGB-1 can induce activation of intracellular signaling pathways via interaction with at least three pattern recognition receptors: Toll-like receptor (TLR) 2, TLR-4, and the receptor for advanced glycation end products (RAGE). The objective of this study was to investigate the role of these receptors in the in vivo response to HMGB-1. Therefore, we first performed a time-series experiment with wild-type (Wt) mice. High-mobility group box 1 induced time-dependent elevations of TNF-alpha, IL-6, monocyte chemoattractant protein 1, and thrombin-antithrombin complex levels in peritoneal lavage fluid and plasma. This inflammatory reaction was accompanied by a prominent and sustained rise in neutrophil counts in the peritoneal cavity. We next administered HMGB-1 to Wt, TLR-2, TLR-4, and RAGE mice. All genotypes showed similar plasma levels of TNF-alpha, IL-6, IL-10, and thrombin-antithrombin complex at 2 h after intraperitoneal injection of HMGB-1. Compared with Wt mice, both TLR-4 and RAGE mice displayed lower TNF-alpha and IL-6 concentrations and lower neutrophil numbers in their peritoneal lavage fluid. In contrast, TLR-2 mice showed increased levels of TNF-alpha and IL-6 in their peritoneal cavity relative to Wt mice. These data indicate that HMGB-1 induces release of cytokines, activation of coagulation, and neutrophil recruitment in vivo via a mechanism that at least in part depends on TLR-4 and RAGE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218854      PMCID: PMC4535325          DOI: 10.1097/SHK.0b013e318186262d

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  17 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

2.  Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury.

Authors:  Kunihiko Izuishi; Allan Tsung; Geetha Jeyabalan; Nathan D Critchlow; Jianhua Li; Kevin J Tracey; Richard A Demarco; Michael T Lotze; Mitchell P Fink; David A Geller; Timothy R Billiar
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

Review 3.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

4.  Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. Requirement for plasma but not for tumor necrosis factor-alpha.

Authors:  Y Aida; M J Pabst
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

5.  High mobility group box 1 protein interacts with multiple Toll-like receptors.

Authors:  Jong Sung Park; Fabia Gamboni-Robertson; Qianbin He; Daiva Svetkauskaite; Jae-Yeol Kim; Derek Strassheim; Jang-Won Sohn; Shingo Yamada; Ikuro Maruyama; Anirban Banerjee; Akitoshi Ishizaka; Edward Abraham
Journal:  Am J Physiol Cell Physiol       Date:  2005-11-02       Impact factor: 4.249

6.  RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.

Authors:  R Kokkola; A Andersson; G Mullins; T Ostberg; C-J Treutiger; B Arnold; P Nawroth; U Andersson; R A Harris; H E Harris
Journal:  Scand J Immunol       Date:  2005-01       Impact factor: 3.487

7.  Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.

Authors:  Jonas Sundén-Cullberg; Anna Norrby-Teglund; Ari Rouhiainen; Heikki Rauvala; Gunilla Herman; Kevin J Tracey; Martin L Lee; Jan Andersson; Leif Tokics; Carl Johan Treutiger
Journal:  Crit Care Med       Date:  2005-03       Impact factor: 7.598

8.  Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.

Authors:  Jong Sung Park; Daiva Svetkauskaite; Qianbin He; Jae-Yeol Kim; Derek Strassheim; Akitoshi Ishizaka; Edward Abraham
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

9.  Contributions of high mobility group box protein in experimental and clinical acute lung injury.

Authors:  Hiroshi Ueno; Tomoyuki Matsuda; Satoru Hashimoto; Fumimasa Amaya; Yoshihiro Kitamura; Masaki Tanaka; Atsuko Kobayashi; Ikuro Maruyama; Shingo Yamada; Naoki Hasegawa; Junko Soejima; Hidefumi Koh; Akitoshi Ishizaka
Journal:  Am J Respir Crit Care Med       Date:  2004-09-16       Impact factor: 21.405

10.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

Authors:  Huan Yang; Mahendar Ochani; Jianhua Li; Xiaoling Qiang; Mahira Tanovic; Helena E Harris; Srinivas M Susarla; Luis Ulloa; Hong Wang; Robert DiRaimo; Christopher J Czura; Haichao Wang; Jesse Roth; H Shaw Warren; Mitchell P Fink; Matthew J Fenton; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

View more
  125 in total

1.  Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.

Authors:  Yuelong Liu; Xiaoyu Xiang; Xiaoying Zhuang; Shuangyin Zhang; Cunren Liu; Ziqiang Cheng; Sue Michalek; William Grizzle; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 2.  The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

3.  Continuous enteral and parenteral feeding each reduces heart rate variability but differentially influences monocyte gene expression in humans.

Authors:  Stephen C Gale; Beth-Ann Shanker; Susette M Coyle; Marie A Macor; Chun W Choi; Steve E Calvano; Siobhan A Corbett; Stephen F Lowry
Journal:  Shock       Date:  2012-08       Impact factor: 3.454

Review 4.  HMGB1 release by inflammasomes.

Authors:  Lieselotte Vande Walle; Thirumala-Dev Kanneganti; Mohamed Lamkanfi
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

5.  Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury.

Authors:  Aaron M Abarbanell; Yue Wang; Jeremy L Herrmann; Brent R Weil; Jeffrey A Poynter; Mariuxi C Manukyan; Daniel R Meldrum
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

6.  Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.

Authors:  Maria Entezari; Daniel J Weiss; Ravikumar Sitapara; Laurie Whittaker; Matthew J Wargo; JianHua Li; Haichao Wang; Huan Yang; Lokesh Sharma; Binh D Phan; Mohammad Javdan; Sangeeta S Chavan; Edmund J Miller; Kevin J Tracey; Lin L Mantell
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

7.  RAGE deficiency attenuates the protective effect of Lidocaine against sepsis-induced acute lung injury.

Authors:  Zhuo Zhang; Jie Zhou; Changli Liao; Xiaobing Li; Minghua Liu; Daqiang Song; Xian Jiang
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

Review 8.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

Review 9.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

10.  High Mobility Group-Box 1 (HMGB1) levels are increased in amniotic fluid of women with intra-amniotic inflammation-determined preterm birth, and the source may be the damaged fetal membranes.

Authors:  Margaret A Baumbusch; Catalin S Buhimschi; Emily A Oliver; Guomao Zhao; Stephen Thung; Kara Rood; Irina A Buhimschi
Journal:  Cytokine       Date:  2016-03-05       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.